Primary multifocal gastrointestinal epithelioid angiosarcoma with MYC amplification: a diagnostic pitfall mimicking poorly differentiated carcinoma: a case report Authors: Mingjie Xu, Hao Cheng, Lijian Xu Published: 2026 ABSTRACT BackgroundPrimary gastrointestinal epithelioid angiosarcoma (EAS) is an extremely rare and aggressive malignancy. Due to its epithelioid morphology and aberrant cytokeratin expression, it frequently mimics poorly differentiated carcinoma, creating significant diagnostic challenges. Furthermore, the molecular landscape of primary EAS, particularly regarding MYC status, remains underrecognized compared to radiation-associated angiosarcomas.Case presentationAn 82-year-old man presented with refractory melena and severe anemia. Imaging revealed multifocal lesions involving the stomach and small intestine. The patient underwent a laparoscopic exploration and multiple segmental resections. Histologically, the tumors consisted of epithelioid cells arranged in solid sheets with extensive hemorrhage. Immunohistochemistry showed strong positivity for CD31, ERG, and CD34, accompanied by diffuse CKpan expression, mimicking carcinoma. Crucially, despite the absence of prior radiotherapy, Next-Generation Sequencing (NGS) of the gastric lesion identified significant MYC gene amplification (copy number 6.7) and a PTPRD nonsense mutation. The patient died three months after surgery.ConclusionsThis case highlights a critical diagnostic pitfall: primary EAS can diffusely express cytokeratins. More importantly, our findings challenge the traditional view that MYC amplification is exclusive to secondary, radiation-associated angiosarcomas. We propose that MYC amplification can act as a driver in primary EAS and may serve as a biomarker for aggressive clinical behavior. Background Angiosarcoma is a rare malignant neoplasm of endothelial origin, accounting for approximately 1–2% of all soft tissue sarcomas [1]. Primary involvement of the gastrointestinal tract is exceedingly uncommon and is associated with an aggressive clinical course and poor prognosis [2]. Epithelioid angiosarcoma (EAS), first described by Weiss and Enzinger [3], represents a distinctive subtype characterized by large epithelioid tumor cells. A major diagnostic challenge arises from the frequent expression of epithelial markers such as cytokeratins, which can lead to misdiagnosis as poorly differentiated carcinoma [4]. At the molecular level, MYC amplification has been considered a hallmark of secondary angiosarcoma associated with radiation or chronic lymphedema [5]. Reports of MYC amplification in primary angiosarcoma are limited. Herein, we report a rare case of primary multifocal gastrointestinal EAS involving both the stomach and small intestine with MYC amplification and highlight the associated diagnostic pitfalls. This case report was prepared in accordance with the CARE guidelines. Case presentation An 82-year-old man presented with a one-month history of melena. Laboratory investigations revealed severe anemia (hemoglobin 54 g/L) and hypoproteinemia. The patient was not immunocompromised and had no history of HIV infection, autoimmune diseases, or immunosuppressive therapy. His past medical history was significant only for hypertension, type 2 diabetes mellitus, and previous benign surgeries (cholecystectomy and renal calculi). The patient denied any history of malignancy or radiotherapy. A thorough physical examination revealed no suspicious cutaneous lesions on the scalp or face, effectively ruling out gastrointestinal metastasis from a primary cutaneous angiosarcoma. Contrast-enhanced computed tomography demonstrated multifocal bowel wall thickening and mass lesions involving the stomach and small intestine, accompanied by enlarged lymph nodes (Fig. 1). Gastroscopy revealed a hemorrhagic subepithelial lesion in the gastric body (Fig. 2A). Fig. 1Preoperative abdominal computed tomography (CT) images. A Axial contrast-enhanced CT scan reveals irregular bowel wall thickening and soft tissue masses in the distal ileum within the right lower quadrant (red arrows). The lesions exhibit heterogeneous enhancement. B A separate axial level demonstrates another segmental lesion in the mid-abdomen showing significant bowel wall thickening and mass effect (red arrow), indicative of the multifocal nature of the tumor Preoperative abdominal computed tomography (CT) images. A Axial contrast-enhanced CT scan reveals irregular bowel wall thickening and soft tissue masses in the distal ileum within the right lower quadrant (red arrows). The lesions exhibit heterogeneous enhancement. B A separate axial level demonstrates another segmental lesion in the mid-abdomen showing significant bowel wall thickening and mass effect (red arrow), indicative of the multifocal nature of the tumor Fig. 2Endoscopic, intraoperative, and gross pathological findings. A Gastroscopy revealed a protruding subepithelial lesion with surface hemorrhage (white arrow) located at the greater curvature of the gastric body. B Intraoperative view showed a dark-red, hemorrhagic tumor mass (white arrow) in the small intestine, with the adjacent segment exhibiting signs of intussusception (white arrow). C The resected small bowel specimen demonstrated multiple, discontinuous, polypoid masses (white arrows) with a dark-red to purplish appearance, confirming the multifocal and hemorrhagic nature of the angiosarcoma Endoscopic, intraoperative, and gross pathological findings. A Gastroscopy revealed a protruding subepithelial lesion with surface hemorrhage (white arrow) located at the greater curvature of the gastric body. B Intraoperative view showed a dark-red, hemorrhagic tumor mass (white arrow) in the small intestine, with the adjacent segment exhibiting signs of intussusception (white arrow). C The resected small bowel specimen demonstrated multiple, discontinuous, polypoid masses (white arrows) with a dark-red to purplish appearance, confirming the multifocal and hemorrhagic nature of the angiosarcoma Due to ongoing gastrointestinal bleeding, a laparoscopic exploration was performed. The surgical intervention included a laparoscopic partial gastrectomy (local tumor excision under intraoperative endoscopic localization), followed by three separate laparoscopic segmental resections of the small bowel to remove the skip lesions (a 20-cm segment at 70 cm distal to the Treitz ligament, a 10-cm segment at the jejunoileal junction, and a 50-cm segment located 40 cm proximal to the ileocecal valve) (Fig. 2B). Gastrointestinal continuity was restored using stapled side-to-side anastomoses. Given the patient’s advanced age and unstable hemodynamic status due to massive hemorrhage, the surgery was performed with a palliative intent to achieve hemostasis and relieve obstruction. Consequently, an extensive regional lymphadenectomy was deemed unsafe and not performed. However, histopathological examination of the sampled mesenteric root lymph nodes confirmed the absence of regional metastasis (0/2). Gross examination of the resected specimens revealed multiple dark-red to purplish polypoid masses infiltrating the bowel wall (Fig. 2C). Microscopically, the tumors were composed of epithelioid cells arranged in solid sheets and nests, with extensive hemorrhage and extravasated erythrocytes (Fig. 3). Tumor cells exhibited abundant eosinophilic cytoplasm, vesicular nuclei, and prominent nucleoli. Intracytoplasmic vacuoles were occasionally observed. Fig. 3Histopathological examination (Hematoxylin-Eosin staining). A Low-power field (H&E, ×100) shows the tumor cells arranged in solid sheets, diffusely infiltrating the bowel wall. B High-power field (H&E, ×400) demonstrates the prominent epithelioid morphology of tumor cells, which are large with abundant cytoplasm and atypical nuclei. Vasoformative spaces and blood lakes are visible between the tumor nests, confirming the vascular origin Histopathological examination (Hematoxylin-Eosin staining). A Low-power field (H&E, ×100) shows the tumor cells arranged in solid sheets, diffusely infiltrating the bowel wall. B High-power field (H&E, ×400) demonstrates the prominent epithelioid morphology of tumor cells, which are large with abundant cytoplasm and atypical nuclei. Vasoformative spaces and blood lakes are visible between the tumor nests, confirming the vascular origin Immunohistochemical staining showed diffuse strong positivity for CD31, ERG, and CD34 (Fig. 4A and B, and 4C), confirming endothelial differentiation. Notably, tumor cells demonstrated diffuse CKpan positivity (Fig. 4D and E), representing a significant diagnostic pitfall. The Ki-67 proliferation index was approximately 50% (Fig. 4F). Markers for adenocarcinoma, gastrointestinal stromal tumor, smooth muscle, and neural differentiation were negative. Fig. 4Immunohistochemical (IHC) staining features. A Tumor cells demonstrate strong, diffuse positivity for CD31 (high-power, ×400), confirming endothelial differentiation. B Tumor cell nuclei are positive for ERG (×400). C The tumor cells also show strong positivity for CD34 (×400), further supporting the vascular lineage. D A lower-power magnification (×100) image of CKpan staining shows an impressively diffuse distribution of cytokeratin positivity across the tumor section, representing a significant diagnostic pitfall that mimics carcinoma. E High-power view (×400) of CKpan staining highlighting the cytoplasmic positivity in epithelioid tumor cells. F The Ki-67 labeling index is high (≈ 50%, ×400), indicating high proliferative activity and aggressive biological behavior Immunohistochemical (IHC) staining features. A Tumor cells demonstrate strong, diffuse positivity for CD31 (high-power, ×400), confirming endothelial differentiation. B Tumor cell nuclei are positive for ERG (×400). C The tumor cells also show strong positivity for CD34 (×400), further supporting the vascular lineage. D A lower-power magnification (×100) image of CKpan staining shows an impressively diffuse distribution of cytokeratin positivity across the tumor section, representing a significant diagnostic pitfall that mimics carcinoma. E High-power view (×400) of CKpan staining highlighting the cytoplasmic positivity in epithelioid tumor cells. F The Ki-67 labeling index is high (≈ 50%, ×400), indicating high proliferative activity and aggressive biological behavior Next-generation sequencing was performed on the Formalin-Fixed Paraffin-Embedded (FFPE) tissue block obtained from the gastric lesion (40% tumor cellularity). Using an in-house 600-gene targeted panel on the MGISEQ-2000 platform, the analysis revealed MYC amplification (copy number 6.7, variant abundance ratio) and a nonsense mutation in PTPRD (p.Gly920Ter, variant allele frequency 4.9%). The tumor mutational burden was low, and microsatellite status was stable. The patient did not receive adjuvant therapy because of poor performance status and died three months postoperatively. Discussion Primary gastrointestinal EAS often presents with nonspecific symptoms such as gastrointestinal bleeding and anemia, resulting in delayed diagnosis [6]. Multifocal involvement, as observed in this case, further complicates clinical and radiological assessment and may mimic multifocal gastrointestinal stromal tumors or lymphoma [7–9]. Given the multifocality and aggressive presentation, metastatic disease must be ruled out; in our case, the absence of liver or lung metastases, combined with negative dermatologic findings, supported a primary multifocal origin. However, the possibility of intra-abdominal “skip” metastases via intramural or mesenteric lymphatics cannot be entirely excluded given the biological behavior of visceral angiosarcomas. In such advanced scenarios, emergency surgery is primarily palliative, aiming to control life-threatening hemorrhage and obstruction. A critical diagnostic pitfall of EAS is aberrant cytokeratin expression, reported in approximately 30–50% of cases [10]. In the present case, diffuse CKpan positivity created a significant diagnostic challenge. In routine clinical practice, vascular markers are not typically included in the initial panel for tumors with obvious epithelioid morphology. Consequently, pathologists might cease investigation at the “CK-positive” finding, erroneously diagnosing poorly differentiated carcinoma. This distinction is clinically critical. Therefore, reliance on epithelial markers alone is insufficient. While CD31 and CD34 are widely used, ERG has demonstrated superior sensitivity and specificity for vascular endothelial tumors and should be prioritized in the diagnostic panel to confirm the diagnosis [11]. The key differential diagnoses and their immunophenotypic features are summarized in Table 1. Table 1Differential diagnosis of primary gastrointestinal epithelioid angiosarcomaTumor TypeKey MorphologyCD31 / ERGCKpan (AE1/AE3)Other Key MarkersEpithelioid AngiosarcomaEpithelioid cells, blood lakes, hemorrhage+ / ++ / - (Can be diffuse*)CD34 (+)Poorly Differentiated CarcinomaCohesive nests, rare gland formation- / -+ (Strong)EMA (+)MelanomaProminent nucleoli, pigment (variable)- / --S-100 (+), SOX10 (+), Melan-A (+)Anaplastic Large Cell Lymphoma (ALCL)Hallmark cells, sinusoidal growth- / --CD30 (+), ALK (+/-), CD45 (+/-)**Epithelioid GISTUniform nuclei, limited stroma- / --CD117 (+), DOG1 (+)Epithelioid MesotheliomaTubulopapillary or solid growth, epithelioid cells- / -+Calretinin (+), WT-1 (+), D2-40 (+)Clear Cell SarcomaNests of pale/clear cells separated by fibrous septa- / --S-100 (+), HMB-45 (+), SOX10 (+)* Diffuse CKpan expression in EAS is a known diagnostic pitfall (seen in ~ 30–50% cases). EMA and p63, though not performed in our case, may also be aberrantly expressed in EAS and are crucial for differentiation against carcinoma**While CD45 is usually positive in lymphomas, ALCL can occasionally be CD45 negative, necessitating CD30 staining Table 1Differential diagnosis of primary gastrointestinal epithelioid angiosarcomaTumor TypeKey MorphologyCD31 / ERGCKpan (AE1/AE3)Other Key MarkersEpithelioid AngiosarcomaEpithelioid cells, blood lakes, hemorrhage+ / ++ / - (Can be diffuse*)CD34 (+)Poorly Differentiated CarcinomaCohesive nests, rare gland formation- / -+ (Strong)EMA (+)MelanomaProminent nucleoli, pigment (variable)- / --S-100 (+), SOX10 (+), Melan-A (+)Anaplastic Large Cell Lymphoma (ALCL)Hallmark cells, sinusoidal growth- / --CD30 (+), ALK (+/-), CD45 (+/-)**Epithelioid GISTUniform nuclei, limited stroma- / --CD117 (+), DOG1 (+)Epithelioid MesotheliomaTubulopapillary or solid growth, epithelioid cells- / -+Calretinin (+), WT-1 (+), D2-40 (+)Clear Cell SarcomaNests of pale/clear cells separated by fibrous septa- / --S-100 (+), HMB-45 (+), SOX10 (+)* Diffuse CKpan expression in EAS is a known diagnostic pitfall (seen in ~ 30–50% cases). EMA and p63, though not performed in our case, may also be aberrantly expressed in EAS and are crucial for differentiation against carcinoma**While CD45 is usually positive in lymphomas, ALCL can occasionally be CD45 negative, necessitating CD30 staining Differential diagnosis of primary gastrointestinal epithelioid angiosarcoma * Diffuse CKpan expression in EAS is a known diagnostic pitfall (seen in ~ 30–50% cases). EMA and p63, though not performed in our case, may also be aberrantly expressed in EAS and are crucial for differentiation against carcinoma **While CD45 is usually positive in lymphomas, ALCL can occasionally be CD45 negative, necessitating CD30 staining The clinical significance of MYC amplification in angiosarcoma remains a subject of ongoing debate. Historically, MYC amplification is regarded as a specific hallmark of radiation-associated or chronic lymphedema-associated angiosarcoma, and is considered rare in primary cases [5]. For instance, Yue et al. reported a case of primary ileal EAS where FISH analysis showed no MYC amplification [12]. However, our case presents a significant deviation from this paradigm. The patient had no history of radiation, yet NGS detected a 6.7-fold MYC amplification in the primary tumor. This finding aligns with emerging evidence, including studies by Geng et al., which identified MYC amplification in a subset of primary angiosarcomas [13, 14]. Recent comprehensive analyses have further emphasized that the incidence and prognostic value of MYC amplification depend heavily on the specific etiological and clinical subgroups of angiosarcoma [15]. It is important to note that MYC amplification does not determine the cellular lineage or aid in the initial differential diagnosis against carcinoma; the distinction between primary and radiation-associated angiosarcoma remains purely clinical. Rather, MYC amplification in this radiation-naïve patient suggests it may serve as a critical prognostic indicator for aggressive biological behavior. Due to tissue exhaustion, further validation via FISH or MYC immunohistochemistry could not be performed, which represents a limitation of this report. Furthermore, the identification of a PTPRD mutation in our case contributes to the growing understanding of the genomic landscape of angiosarcoma [16]. The variant allele frequency (VAF) of the PTPRD mutation was 4.9%, which is consistent with the estimated tumor cellularity. In the comprehensive genomic characterization by the Angiosarcoma Project, PTPRD alterations were identified among the genomic spectrum of angiosarcomas, highlighting its potential role in this malignancy [16]. PTPRD typically acts as a tumor suppressor by dephosphorylating STAT3. Its loss-of-function (via the p.Gly920Ter mutation) may lead to STAT3 hyperactivation, potentially contributing to the rapid clinical deterioration observed in this patient. This case expands the molecular spectrum of primary EAS and underscores the value of broad NGS panels in uncovering potential therapeutic targets and prognostic biomarkers in this aggressive malignancy. Conclusions Primary gastrointestinal epithelioid angiosarcoma is a rare malignancy that poses significant diagnostic challenges. Awareness of cytokeratin-positive diagnostic pitfalls and appropriate use of vascular markers like ERG are essential. MYC amplification may be present in primary cases without prior radiation exposure and could indicate aggressive biological behavior.